Clinical Library · Hormonal Health
Inositol vs berberine for insulin resistance in PCOS / PMOS
Short answer
Myo-inositol is the gentler, better-studied choice for cycles and ovulation. Berberine has stronger data on blood sugar and cholesterol but is harder on the stomach and interacts with more medicines. They work through different pathways, so many clinicians see them as partners rather than rivals. Neither replaces medical care.
Why insulin resistance matters in PCOS / PMOS
PCOS was renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026 partly to reflect that it is not only about the ovaries. Many women with the condition have insulin resistance: the body makes insulin, but cells respond to it less well. Higher insulin can push the ovaries to make more androgens, which is linked to irregular cycles, acne and hair changes. Read more in PCOS is now PMOS.
Food, movement, sleep and stress come first. Supplements such as inositol and berberine are sometimes added alongside those habits, not instead of them.
How inositol works
Myo-inositol and D-chiro-inositol are naturally present in food and made by the body. Inside cells they help pass on insulin's signal. Trials in women with PCOS have looked at cycle regularity, ovulation and metabolic markers, with generally encouraging but mixed results. Some studies have investigated a 40:1 myo to D-chiro combination. Current international guidance does not recommend a specific inositol type, dose or combination. See how to take inositol.
How berberine works
Berberine is a plant compound that activates AMPK, the same energy-sensing switch that metformin influences. Human trials report improvements in fasting glucose, insulin and cholesterol, and a few PCOS trials report metabolic benefits. Stomach side effects are the main drawback, which is why it is usually split across meals. Our berberine vs metformin article covers the trials in detail.
Side by side
| Inositol | Berberine | |
|---|---|---|
| How it works | Acts as an insulin 'second messenger' inside cells | Activates AMPK, the cell's energy switch |
| Strongest evidence | Cycle regularity, ovulation | Fasting glucose, insulin, cholesterol |
| Doses studied | Commonly 2–4 g myo-inositol a day | Commonly 900–1,500 mg a day, split with meals |
| Tolerance | Very well tolerated | Bloating, loose stools or constipation are common at first |
| Medicine interactions | Few known | Several — check with your doctor |
| Pregnancy | Discuss with your doctor | Avoid |
Which one fits which goal
- Irregular cycles, trying to ovulate: inositol has the larger body of PCOS-specific research.
- Raised fasting sugar or cholesterol: berberine has the stronger metabolic data.
- Sensitive stomach: inositol is usually easier to live with.
- Already on metformin: talk to your doctor before adding berberine.
Taking them together
Because they act differently, inositol and berberine are often combined, and no harmful interaction between the two is known. Give any routine about 12 weeks before judging it, and ask your doctor for repeat tests such as fasting glucose or HbA1c rather than going by feel alone.
Where Ova Balance fits
Ova Balance is a once-daily sachet that includes myo-inositol 2000 mg and D-chiro-inositol 50 mg alongside berberine HCl 300 mg, plus Quatrefolic® L-5-MTHF, vitamin D3, magnesium, zinc and chromium. The berberine amount is below the doses used in most berberine trials, so it is designed as daily nutritional support, not a treatment. Check the latest availability and label on the product page.
Frequently asked questions
Is inositol or berberine better for PCOS insulin resistance?
Neither is a clear winner in the evidence. Myo-inositol is the better-studied option for cycle regularity and ovulation, and it is very well tolerated. Berberine has stronger trial data on fasting glucose and lipids but causes more stomach upset. Many women and clinicians consider them complementary rather than competing.
Can I take inositol and berberine together?
They act through different pathways, so they are often combined, and no harmful interaction between them is known. If you take metformin, insulin or other glucose-lowering medicine, speak to your doctor first because berberine may add to their effect.
How long do inositol and berberine take to work?
Most trials measure changes after about 12 weeks. Some people notice steadier energy earlier, but cycle and metabolic changes should be judged over roughly three months, ideally with your doctor's tests.
What is the 40:1 inositol ratio?
It is a myo-inositol to D-chiro-inositol ratio that some studies have investigated. Current international guidance does not recommend a specific inositol type, dose or combination, so treat it as one studied option rather than a proven standard.
Who should avoid berberine?
Avoid berberine in pregnancy and while breastfeeding, and check with your doctor if you take diabetes medication, blood thinners, ciclosporin or several other prescription medicines, because berberine can affect how some drugs are processed.
This article is for general information and is not medical advice. Speak to your gynaecologist or doctor before starting a supplement, especially if you are pregnant, trying to conceive or taking medicine.
The formulation behind this article
Ova Balance
40:1 Myo:D-Chiro inositol with Berberine HCl & Quatrefolic®
Vitamin D3 (Cholecalciferol)
600 IU (15 mcg)Form used: Vitamin D3 (cholecalciferol)
Ova Balance provides 600 IU (15 mcg) of vitamin D3 per sachet. Vitamin D supports calcium absorption and normal bone, muscle and immune function. The cited trial studied vitamin D status at a different dose; it does not establish finished-product PCOS or fertility benefits.
Myo-Inositol
2000 mgForm used: Pharmaceutical-grade myo-inositol powder, dosed in a 40:1 ratio with D-chiro inositol
Restores insulin signalling, ovulation and cycle regularity, backed by the research-backed 40:1 Myo:D-Chiro ratio.
D-Chiro Inositol
50 mgForm used: D-chiro inositol, dosed at 50 mg to hold the 40:1 ratio with myo-inositol
The original PCOS breakthrough, improves insulin sensitivity, androgen balance and ovulation when paired with myo-inositol in the 40:1 ratio.
Quatrefolic® (L-5-MTHF)
400 mcgForm used: Quatrefolic® (6S)-5-MTHF glucosamine salt, 400 mcg DFE
Patented (6S)-5-methyltetrahydrofolate glucosamine salt, the active, body-ready form of folate. Bypasses the MTHFR conversion step, so it works for everyone (including the ~30-50% with C677T variants). Delivered at 400 mcg DFE per sachet.
Berberine HCl
300 mgForm used: Berberine hydrochloride (HCl), 300 mg
Plant alkaloid that helps support insulin sensitivity, lipid balance and metabolic health, delivered at the 300 mg dose used in published PCOS and metabolic trials.
Food supplement, not a medicine. Ingredient research describes individual actives and their delivery forms, not finished-product outcomes. Consult a clinician if pregnant, lactating or on prescription medication.
References
Every in-text claim in this article is credited to the original researchers and peer-reviewed journal below. Key studies cited: Unfer V et al. (2017, Endocrine Connections); Facchinetti F et al. (2015, European Journal of Obstetrics & Gynecology and Reproductive Biology); Yin J et al. (2008, Metabolism); Lan J et al. (2015, Journal of Ethnopharmacology).
- [1]
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
- Author(s)
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J
- Year
- 2017
- Journal
- Endocrine Connections
- Citation
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/29042448/
- [2]
Results from the International Consensus Conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology
- Author(s)
- Facchinetti F, Bizzarri M, Benvenga S, D'Anna R, Lanzone A, Soulage C, et al.
- Year
- 2015
- Journal
- European Journal of Obstetrics & Gynecology and Reproductive Biology
- Citation
- Facchinetti F, Bizzarri M, Benvenga S, et al. Results from the International Consensus Conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology. Eur J Obstet Gynecol Reprod Biol. 2015;195:72-76.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/26479442/
- [3]
Efficacy of berberine in patients with type 2 diabetes mellitus
- Author(s)
- Yin J, Xing H, Ye J
- Year
- 2008
- Journal
- Metabolism
- Citation
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/18442638/
- [4]
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
- Author(s)
- Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G
- Year
- 2015
- Journal
- Journal of Ethnopharmacology
- Citation
- Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015;161:69-81.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/25498346/
Citations follow AMA format. TruWe does not own or endorse the linked journals; all rights and credit remain with the original authors and their respective publishers.
